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The viral RNA (vRNA) genome of influenza A virus is replicated in the nucleus, exported to the cytoplasm
as ribonucleoproteins (RNPs), and trafficked to the plasma membrane through uncertain means. Using
fluorescent in situ hybridization to detect vRNA as well as the live cell imaging of fluorescently labeled RNPs,
we show that an early event in vRNA cytoplasmic trafficking involves accumulation near the microtubule
organizing center in multiple cell types and viral strains. Here, RNPs colocalized with Rab11, a pericentriolar
recycling endosome marker. Cytoplasmic RNP localization was perturbed by inhibitors of vesicular trafficking,
microtubules, or the short interfering RNA-mediated depletion of Rab11. Green fluorescent protein (GFP)-
tagged RNPs in living cells demonstrated rapid, bidirectional, and saltatory movement, which is characteristic
of microtubule-based transport, and also cotrafficked with fluorescent Rab11. Coprecipitation experiments
showed an interaction between RNPs and the GTP-bound form of Rab11, potentially mediated via the PB2
subunit of the polymerase. We propose that influenza virus RNPs are routed from the nucleus to the
pericentriolar recycling endosome (RE), where they access a Rab11-dependent vesicular transport pathway to
the cell periphery.
Influenza A virus is a ubiquitous pathogen of homeothermic
vertebrates with the capacity to cause seasonal epidemics and
occasional, potentially devastating outbreaks in humans (55).
The virus has a single-stranded RNA genome split into eight
segments that encode between 10 and 12 polypeptides depend-
ing on the virus strain (61). The viral RNA (vRNA) segments
are encapsidated into ribonucleoprotein (RNP) particles by
the viral RNA-dependent RNA polymerase and a single-
strand RNA-binding protein, NP (40). Once delivered to the
cell nucleus at the start of infection, they act as independent
units for the purposes of transcription and replication of the
virus genome. Virus assembly subsequently takes place at the
apical plasma membrane of infected cells; here, the three viral
membrane proteins (HA, NA, and M2) join with the M1 ma-
trix protein, small amounts of the NEP/NS2 protein, and the
RNPs to form new enveloped virus particles through a process
of budding. This assembly phase of the virus life cycle is not
especially well understood but is thought to result from a
cascade of protein-protein interactions between the viral com-
ponents, as well as probable RNA-RNA interactions between
specific vRNAs that ensure a complete genome is incorporated
(27, 36). Unlike many other enveloped viruses, the formation
of a mature virus particle does not depend on the cellular
ESCRT pathway (11, 15, 58) but requires the function of the
small GTPase Rab11 (10) and the viral M2 protein (48).
A further aspect of the viral life cycle that is imperfectly
understood concerns the intracellular trafficking of the viral
genome. The nuclear export of newly synthesized RNPs in-
volves sequential interactions between the RNPs, M1, and
NEP and the cellular nuclear export factor Crm1 (8). However,
the mechanisms that then transport RNPs across the cytoplasm
to the sites of budding at the apical plasma membrane are
poorly defined. Individual RNPs range in size from 2.5 to 6
MDa (depending on the length of the vRNA segment), and
thus simple diffusion is unlikely to operate over long distances.
On general principles, as well as precedents from other viruses
(41), the involvement of one or more arms of the cytoskeleton
seems likely. Although NP has been defined as an actin-bind-
ing protein (19) and shown to partially colocalize with actin at
the plasma membrane (5, 53), direct evidence for a role in
RNP transport is lacking. Instead, an intact cortical actin web
seems to be required to support filamentous viral budding (47,
53). Cytoplasmic RNPs have been suggested to colocalize with
microtubules (34), but although (like actin) tubulin has been
found to copurify with RNPs and be present in virions (31, 52),
direct evidence for a role in trafficking is sparse. In general,
pharmacologic interference with the cytoskeleton (after virus
entry) has relatively slight effects on influenza A virus replica-
tion outside certain drugs that also interfere with viral protein
synthesis (4, 22, 34, 45, 47, 50, 53). Thus, this aspect of the virus
life cycle has many unresolved questions.
Here, we provide positive evidence that the transport of the
viral genome from the nucleus to the cell periphery does in-
deed involve the microtubule network. Furthermore, we pro-
vide a new model for efficient RNP transport that involves the
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piggybacking of RNPs onto the vesicular transport network at
the pericentriolar RE via an interaction between PB2 and
Rab11.
MATERIALS AND METHODS
Cells, viruses, and drugs. Human embryonic kidney 293T, Madin-Darby ca-
nine kidney (MDCK), and human alveolar basal epithelial cells (A549) were
cultured as previously described (12). Two subtypes of human virus were used,
A/Puerto Rico/8/34 (PR8; H1N1) and A/Udorn/301/72 (Udorn; H3N2) (47), as
well as A/duck/Eng/8/1/1962 (Duck/Eng; H4N6) (24) and A/Eq/Newmarket/
11/03 (Eq/Nkt; H3N8) (gift of Janet Daly). Virus infections were carried out at
a multiplicity of infection (MOI) of 5 to 10 in serum-free medium. Drugs were
from Sigma and were used at 20 (nocodazole), 150 (monensin), 5 (demecolcine),
or 10 M (paclitaxel) final concentrations.
Plasmids and transfections. A plasmid encoding green fluorescent protein
(GFP)-tagged constitutively active (CA) (Q67L) Rab8 protein was a gift of
Folma Buss (49). GFP-tagged wild-type (WT) and CA (Q70L) Rab11a and CA
(Q67L) Rab4 constructs are described elsewhere (10, 16, 51). mCherry-C2 ver-
sions of both Rab11 proteins were created by PCR amplifying and cloning the
Rab11a genes into EcoRI and BamHI sites in the polylinker of an mCherry
version of pEGFP-C2 from Clontech. Primers TCGAGAATTCATGGGCACC
CGCG (rab11aF) and TCGAGGATCCTTAGATGTTCTGACAGCACTGCA
(rab11aR) were used. pCDNA3 plasmids used to synthesize fluorescent in situ
hybridization (FISH) probes to detect vRNA from segments 1, 2, 4, and 7 are
described elsewhere (2, 23, 35). Plasmids used for the minireplicon system are
described in reference 35, except for GFP-NP (29) and pPolI segments 7 and 8
(17). To reconstitute GFP-tagged RNPs, 1 105 293T cells were transfected with
pcDNA3 PB1, PB2, PA (130 ng each), NP (80 ng), GFP-NP (50 ng), and pPolI
segments 7 and 8 (130 ng each) using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions, incubated overnight, and imaged around 24 h
later. The treatment of cells with short interfering RNAs (siRNAs) against
Rab11a and Rab11b or with nontargeting siRNAs was carried out as previously
described (10).
Microscopy. FISH analysis was performed essentially as described in reference
2. To generate FISH probes, pCDNA3 plasmids containing segments 1, 2, 4, or
7 were cut with XbaI and transcribed as described previously (42), except that T7
RNA polymerase was used to produce a positive-sense probe to detect vRNA.
Probes were directly labeled using cyanine 5-UTP (Perkin Elmer) or Chroma-
Tide Alexa Fluor 488-5-UTP (Invitrogen). Immunofluorescence was carried out
as described previously (53). Reagents included mouse monoclonal antibody to
-tubulin (ab11316; Abcam), sheep polyclonal antibody to TGN46 (AHP500G;
AbD-Serotec), rabbit polyclonal anti-NP (2915) (37), rat monoclonal antibody to
-tubulin (YL1/2 MCA77G; AbD-Serotec), and mouse monoclonal antibody to
GM130 (610822; BD Transduction Laboratory).
For live imaging, cells were grown in chambered glass-bottomed dishes (Lab-
Tek) and maintained at 37°C in Leibovitz L-15 CO2-independent medium
(Gibco) during imaging. Samples were imaged using Zeiss LSM510 or Leica SPE
or TCS-NT confocal microscopes and postprocessed using Adobe Photoshop
and ImageJ (NIH). Unless otherwise stated, single optical sections are shown.
Particle-tracking analysis was done using the MtrackJ plugin (32). Colocalization
analysis was done using the intensity correlation analysis WCIF plugin (http:
//www.uhnresearch.ca/facilities/wcif/imagej/appendix_1.htm).
For fluorescence recovery after photobleaching (FRAP) analysis, cells were
imaged on a Zeiss LSM 510 confocal microscope using a 63 magnification,
1.4-numeric-aperture objective. Photobleaching was performed using 100%
power from a 30-mW 488-nm laser line running at 6.1 A within a 1.7- by 1.7-m
square, which took a total of 0.5 s. Images were captured at 0.7% of laser output
at 0.25-s intervals, obtaining 512- by 512-pixel images. Samples were corrected
for background fluorescence and acquisition photobleaching as described previ-
ously (29). The averages of multiple individual cells are presented.
The Duolink II fluorescent proximity assay (Olink Bioscience) was used in
conjunction with standard confocal microscopy to detect epitopes within an
40-nm distance (54). Samples were fixed, permeabilized, and stained with
primary antibodies as described above and then stained with oligonucleotide-
labeled secondary antibodies. Samples were treated with a ligation solution
(allowing nearby oligonucleotide probe pairs to form a closed circle), and an
amplification solution containing polymerase and fluorescently labeled oligonu-
cleotides was added, allowing rolling-circle amplification and the detection of a
discrete fluorescent spot (according to the Duolink II fluorescence user manual).
Signal was expressed as the number of fluorescent dots per cell in a given field
of view and compared to the background signal observed in mock-infected cells
and cells treated with one relevant and one irrelevant antibody.
Pulldowns and Western blotting. Pulldowns of GFP-tagged proteins were
performed using GFP-Trap beads (Chromotek). Confluent 6-well dishes of 293T
cells were transfected with 350 ng of each plasmid and, where applicable, were
infected 48 h later with virus for 6 h. Cells were lysed in 500 l of 50 mM
Tris-HCl, pH 8, 25% glycerol, 0.5% NP-40 substitute (Fluka), 200 mM NaCl, 1
mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and
protease inhibitor cocktail (Roche) on ice for 30 min. Clarified samples then
were preabsorbed on glutathione Sepharose beads (Amersham Biosciences) for
30 min, and the supernatant was bound to GFP-Trap beads for 2 h at 4°C. Beads
were washed before and after sample binding with 10 mM Tris HCl, pH 8, 0.1%
NP-40 substitute, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, and protease
inhibitor cocktail. Bound proteins were eluted by being boiled in SDS-PAGE
sample buffer. Bound RNA was extracted by adding 1 ml of Trizol (Invitrogen)
and 200 l chloroform directly to the Trap beads and recovered by ethanol
precipitation. Specific RNA species were detected by reverse transcriptase-ra-
diolabeled primer extension followed by urea-PAGE and autoradiography es-
sentially as described previously (35, 46). Western blotting was performed ac-
cording to standard procedures and imaged using a LiCor Biosciences Odyssey
near-infrared platform as described previously (11). Antibodies used included
mouse monoclonal antibodies against Rab11a (ab78337; AbCam), GFP (JL8;
632380; Clontech), and influenza M2 (14C2; ab5416; AbCam), rat monoclonal
alpha tubulin (YL1/2 MCA77G; AbD-Serotec), and rabbit polyclonal antisera to
whole PR8 virions PR8 M1 (A2917) (2), PB1 (V19), PA (V35) (18), PB2
(2N580) (39), and NP (2915) (37).
RESULTS
The influenza virus genome is not thought to exist normally
as naked RNA but rather as encapsidated RNP particles con-
taining one copy of a trimeric RNA polymerase and multiple
copies of the nucleoprotein (40). Accordingly, the majority of
studies that have investigated the localization of the viral ge-
nome in cells by microscopy have utilized indirect immunoflu-
orescence against NP as a proxy marker for vRNA. However,
our recent development of FISH protocols for the direct de-
tection of influenza virus RNAs (2, 26, 42) allow more direct
visualization of genome trafficking.
We carried out a time course experiment in which MDCK
cells were fixed and stained at various times postinfection (p.i.)
for vRNA from segments 1 and 4. Early in infection, obvious
vRNA staining of the nucleoplasm but not the nucleoli was
apparent (Fig. 1A, 5 h). At later times, staining became in-
creasingly biased toward the cytoplasm, such that by 12 h p.i.
many nuclei appeared empty of vRNA (Fig. 1A). This time-
dependent shift from predominantly nuclear to predominantly
cytoplasmic localization is broadly consistent with that ex-
pected from the immunofluorescent staining of NP (9, 21, 30).
However, at intermediate times postinfection, many cells also
showed bright perinuclear foci of vRNA (Fig. 1A, arrows).
Similar perinuclear accumulations of vRNA were seen in
other cell types, including A549 cells (see later) and 293T
cells (Fig. 1B). The perinuclear accumulation of NP has
been noted previously (10, 34), and consistently with this
information, the structures seen here contained both vRNA
and NP, although the FISH staining of the viral genome
generally was proportionally more intense (Fig. 1B). The
examination of Z-stack animations of serial planes of focus
taken throughout the body of the cells showed that these
perinuclear foci contained more than one segment and
tended to be around the midline of the cell or slightly
higher, but they were below the level of the plasma mem-
brane (see Movie S1 in the supplemental material). When
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multiple cells were examined from replicate experiments
and scored according to whether perinuclear vRNA staining
was present, it was apparent that these structures appeared
soon after the onset of vRNA nuclear export and reached a
maximum around 7 h p.i., and although they sometimes
persisted throughout infection, they generally became less
prominent later in infection (Fig. 1C).
To investigate this perinuclear accumulation further, we first
asked whether it was a feature of influenza viruses in general or
specific to the PR8 strain. We also tested whether the perinu-
clear body represented a specific cellular location by staining
the microtubule organizing center (MTOC) with anti--tubu-
lin. As before, 293T cells infected with PR8 virus contained a
prominent perinuclear focus of vRNA staining at 6 h p.i. that,
under high magnification, was seen to consist of punctate dots
surrounding the MTOC (Fig. 2). This was a common occur-
rence, as 45 of 51 infected cells examined from two indepen-
dent experiments displayed this pattern of localization. Similar
structures that in all cases surrounded the -tubulin staining
also were seen in cells infected with the human H3N2 Udorn
strain as well as with a low-pathogenicity Duck/Eng H4N6
avian virus and the H3N8 equine influenza virus strain Eq/Nkt
FIG. 1. Time course of vRNA localization in infected cells shows the perinuclear accumulation of vRNA at intermediate times postinfection.
MDCK (A) or 293T (B) cells were infected (or mock infected) with PR8 virus and fixed and stained for specific vRNA segments (A) and both
vRNA segments and NP (B) at the indicated times p.i. Merged images also include 4,6-diamidino-2-phenylindole (DAPI) staining (blue) except
in the higher-magnification images in panel B, where for clarity the outline of the DAPI staining is indicated by dashed white lines. (C) The
percentage (means  SE) of cells showing an obvious perinuclear accumulation of vRNA was scored at various times p.i. A minimum of 200 cells
from three independent experiments were counted. Also see Movie S1 in the supplemental material.
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(Fig. 2). The same outcome was obtained when the experiment
was repeated with MDCK cells (data not shown).
The consistent localization of vRNA around the MTOC
suggested its interaction with one or more of the similarly
localized cellular organelles; this was investigated by double
staining for components of cellular vesicular transport path-
ways. Little colocalization (Pearson correlation coefficient of
0.068  0.008, from four fields of view) was seen between
perinuclear vRNA and GM130, a marker for the cis-Golgi
network (Fig. 3A). A similar result (Pearson coefficient of
0.179  0.06, n  3) was obtained when TGN46 was used as a
marker for the trans-Golgi compartment, and although both
vRNA and the cellular protein distributed as a pattern of
perinuclear spots, the examination of high-magnification im-
ages showed that these patterns were distinct and largely sep-
arate (Fig. 3A, inset). A similar lack of colocalization was
obtained when EEA1, a marker for early endosomes, or cal-
nexin, a marker for the endoplasmic reticulum, were compared
to vRNA (Pearson coefficients of 0.037  0.03, n  3, and
0.087  0.05, n  3, respectively; image data not shown). We
have shown previously that cytoplasmic NP colocalizes with
Rab11, including at a perinuclear structure (10). Unfortu-
nately, the epitopes seen by our Rab11 antisera did not survive
the FISH process (data not shown), making it impossible to
test whether vRNA also colocalized with the endogenous pro-
tein. However, when a transfected GFP-tagged constitutively
active Rab11 (GFP-Rab11 CA) (16) was used as a marker for
the RE, a high degree of colocalization was seen with the
perinuclear foci of vRNA (Fig. 3B). The Pearson coefficient for
vRNA (CA Rab11; 0.541  0.05, n  4) was significantly
higher (P 	 0.0001) than the overlap seen for TGN46 or the
other cellular markers. This degree of colocalization also was
maintained when more dispersed cytoplasmic foci of vRNA
were examined at a later time point (Fig. 3B, 12 h).
The colocalization of vRNA with Rab11-positive structures
near the MTOC soon after the onset of genome replication
and nuclear export suggested that cytoplasmic vRNA traffick-
ing involves the cellular vesicular transport pathway and there-
fore the microtubule network. Accordingly, we tested the ef-
fects of the pharmacological disruption of these processes on
vRNA localization. In untreated MDCK cells, the viral ge-
nome was predominantly cytoplasmic late in infection, concen-
trating at the apical plasma membrane, while NP showed a
similar distribution but with additional bright foci in the nuclei
(Fig. 4A). Treatment with the microtubule-depolymerizing
agent nocodazole led to the loss of the apical polarization of
vRNA and NP, and instead optical sections through the mid-
line of the cells showed their pronounced accumulation at
lateral membranes. A similar outcome of aberrant vRNA lo-
calization to lateral membranes was seen with demecolcine,
another drug that destablizes microtubules, as well as when
cells were treated with paclitaxel, a microtubule-stabilizing
agent, but instead of localizing to lateral membranes it formed
prominent aggregates toward the cell periphery. The disrup-
tion of vesicular trafficking with the ionophore monensin also
altered vRNA trafficking, leading to a persistence of the prom-
inent perinuclear foci of vRNA staining normally seen earlier
in infection, as well as a degree of NP nuclear retention. We
also examined the effect of the drugs on virus replication by
titrating released virus from the cell supernatants. This showed
modest but consistent decreases of around 4-fold after drug
treatment (Fig. 4B). The Western blot analysis of selected virus
FIG. 2. Perinuclear accumulation of vRNA is a general feature of influenza A viruses. 293T cells were infected (or mock infected) with the
indicated viruses, fixed at 6 h p.i., and stained for segment 7 vRNA and -tubulin. Merged images include a 4,6-diamidino-2-phenylindole (DAPI)
channel shown in blue. Insets show higher-magnification images of the boxed areas.
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polypeptides showed no major effect on viral protein accumu-
lation (Fig. 4C). Overall, these data are consistent with cyto-
plasmic vRNA trafficking involving the microtubules and the
cellular vesicular transport pathway.
To further investigate the hypothesis that RNP cytoplasmic
trafficking involves the microtubule network, we established a
system in which the movement of RNPs could be investigated
in living cells using GFP-tagged NP. Because of the difficulty of
FIG. 3. Relationship of the perinuclear accumulation of vRNA to cellular structures. (A and B) 293T cells were infected with PR8 virus, fixed at the
times shown, and stained for segment 7 vRNA (A) and the indicated cellular polypeptides. (B) The cells first were transfected with GFP-Rab11 CA, which
was detected by GFP fluorescence. Merged images include a 4,6-diamidino-2-phenylindole (DAPI) channel shown in blue. Insets show higher-
magnification images of the boxed areas.
FIG. 4. Effect of inhibitors of cellular trafficking on RNP localization. MDCK cells were infected with PR8 virus and at 90 min p.i. were treated with the
indicated drugs or left untreated. (A) At 8 h p.i. (or 6.5 h p.i. for monensin) the cells were fixed and processed for FISH to detect segment 2 vRNA (red) and
counterstained for NP protein (green). Small panels show z axis reconstructions. The scale bar indicates 16 m. (B) Titers of supernatants were determined by
plaque assay, and the results were plotted as the mean percentageSEM (n 3) of the value from untreated cells. (C) Cell lysates were analyzed by SDS-PAGE
and Western blotting, followed by densitometry for the indicated viral proteins. The means and ranges from two independent experiments are plotted.
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introducing a large protein tag such as GFP into the viral
genome, we turned to a plasmid-based minireplicon system in
which the three polymerase proteins (3P), NP, and synthetic
vRNAs are transcribed from cDNA (35, 38). Although our
GFP-NP construct can functionally replace WT NP in the
minireplicon setting (29), RNPs were reconstituted by trans-
fecting a mixture of tagged and untagged NP to reduce the
density of the GFP tag. Also, since the nuclear export of the
viral genome requires both M1 and NEP proteins (8), we
supplied segments 7 and 8 as vRNA templates, thus ensuring
the expression of these proteins. To validate this system, we
first tested for the successful reconstitution of RNPs by bio-
chemical means. When lysates from transfected cells were in-
cubated with GFP-affinity beads, PB2 coprecipitated with
GFP-NP but not GFP (Fig. 5A, compare lanes 4 and 6), sug-
gesting RNP formation. Confirming this, vRNA also was de-
tectable in the bound fraction of lysates from cells containing
3P and GFP-NP, but not 3P and GFP or 2P (lacking PB2) and
GFP-NP (Fig. 5B). We next examined the distribution of
GFP-NP and vRNA in fixed cells. In control transfections
lacking the PB2 subunit and thus a functional polymerase
complex, the majority of GFP-NP was nuclear and relatively
little signal was seen for segment 7 vRNA, with only a few
nuclear foci of staining evident that potentially resulted from
plasmid rather than viral transcription (Fig. 5C, image i). In
contrast, when the full 3P-NP complex was present, bright
nuclear and cytoplasmic vRNA staining was evident, with the
latter often concentrating in a perinuclear structure as well as
smaller, more dispersed foci throughout the cytoplasm (Fig.
5C, images ii to vi). When GFP-NP was included with the
3P-NP complex, the strong colocalization of the vRNA and
GFP signal was seen both at the perinuclear region (image iii)
and for the dispersed cytoplasmic puncta (image iv, inset).
Similarly, when GFP-NP was replaced with a GFP-tagged con-
FIG. 5. Reconstitution of cytoplasmic RNP trafficking with GFP-tagged components. 293T cells were transfected with plasmids expressing
segment 7 and 8 vRNAs and the minimal protein components of an influenza RNP, the three polymerase proteins (3P; or, as a nonfunctional
control, two polymerase proteins lacking PB2 [2P]) and NP, as well as with plasmids expressing GFP-NP, GFP-Rab11 CA, or GFP as labeled.
(A) At 48 h posttransfection, cells were lysed and analyzed by Western blotting for GFP and PB2 before (input) or after (bound) GFP-Trap affinity
selection. (B) Bound RNA was analyzed by primer extension for segment 7 (vRNA) or 5S rRNA. A sample of infected cell RNA was analyzed
in parallel as a marker (total). (C) At 24 h posttransfection, cells were fixed and stained for segment 7 vRNA by FISH. Nuclei were stained with
4,6-diamidino-2-phenylindole (DAPI). Scale bar, 5 m.
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stitutively active (CA) Rab11 mutant, good colocalization was
seen between vRNA and the fluorescent Rab11 protein both at
the perinuclear region (image v) and for the smaller cytoplas-
mic granules (image vi). Thus, the RNP reconstitution assay
successfully recapitulated the perinuclear accumulation of cy-
toplasmic vRNA seen in authentic viral infection, and further-
more it confirmed good cytoplasmic colocalization between
GFP-NP and vRNA as well as between GFP-Rab11 CA and
vRNA.
We next used this system to investigate the trafficking of viral
RNPs in living cells by collecting time-lapse movies. Cells dis-
playing the prominent perinuclear accumulation of GFP-NP
(which thus likely contained successfully reconstituted RNPs)
also showed the presence of many additional, smaller foci of
NP in the cytoplasm (Fig. 6A). Many of the small GFP-NP foci
remained approximately static (except for Brownian-type
movement, which is defined here as random) during the ob-
servation period, but some exhibited the classic saltatory pat-
tern of intermittent but rapid movement expected for micro-
tubule-based transport. (see Movies S2 and S3 in the
supplemental material; example tracks and selected frames are
shown in Fig. 6A). Other particles showed more processive
(defined as visible for at least five consecutive frames) but
generally slower movement. When the speeds of multiple par-
ticles exhibiting the various classes of movement were mea-
sured, those that displayed random Brownian motion moved at
an average of 0.12  0.07 m/s, while those exhibiting proces-
sive movement traveled at 0.25  0.11 m/s. In contrast, par-
ticles showing saltatory and/or bidirectional movement trav-
eled at much faster speeds of up to nearly 3 m/s with an
average of 0.81  0.40 m/s (Fig. 6B and C). The large peri-
nuclear accumulation remained mostly stationary, although its
shape continually changed throughout observation and smaller
particles could be seen to apparently both merge with and
depart from it (see Movie S2 in the supplemental material).
To test the involvement of microtubules in RNP movement,
transfected cells were treated with a panel of drugs that inter-
fere with microtubule and/or vesicular transport and imaged
up to 3 h later. From this, it was apparent that monensin
treatment had a relatively slight (although statistically signifi-
cant) effect on RNP movement (Fig. 6D), in contrast to its
dramatic effect on vRNA trafficking in infected cells (Fig. 4).
Under the shorter timescale of the live-cell imaging experi-
ments, it is possible that monensin blocks the formation of new
RE vesicles without disturbing the trafficking of preexisting
ones (33). However, all drugs targeting microtubules caused a
statistically significant, nearly complete loss of the fast, salta-
tory class of movement (Fig. 6D; an example of a nocodazole-
treated cell is shown in Movie S4 in the supplemental mate-
rial). These data further support the hypothesis that RNP
cytoplasmic trafficking is mediated in part by the microtubule
network.
Based on the observation that the number of cells displaying
an obvious perinuclear accumulation of vRNA increased and
then decreased during the infection cycle (Fig. 1C), we hypoth-
esized that RNPs localized there first before distributing to the
cell periphery to be assembled into budding virions. Therefore,
we used fluorescence recovery after photobleaching (FRAP) to
examine whether GFP-tagged NP in the perinuclear compart-
ment dynamically exchanges. A bleach area large enough to
cover the entire perinuclear compartment was defined (Fig.
7A) to ensure that FRAP recovery represented the exchange
of GFP-NP with the cytoplasm rather than an internal rear-
rangement of protein in the compartment or movement in the
z axis. Relatively slow but consistent recovery of fluorescence
within the perinuclear body was observed, on average to
10.8%  1.3% of the initial value during a period of 85 s (Fig.
7A to C; also see Movie S5 in the supplemental material),
indicating measurable but limited exchange with the perinu-
clear compartment during the period of a minute or so. Thus,
the perinuclear compartment is not static, but neither is there
rapid exchange with GFP-NP in the cytoplasm; this finding is
compatible with the directed transport of RNPs rather than
free diffusion.
Since cytoplasmic NP and vRNA colocalized well with en-
dogenous and CA forms of Rab11 in fixed cells (10) (Fig. 3 and
5), we tested whether this extended to living cells by transfect-
ing cells with plasmids to reconstitute cytoplasmic GFP-tagged
RNPs as before and additionally with an otherwise WT RFP-
tagged Rab11. An excellent degree of colocalization between
cytoplasmic puncta of GFP-NP and RFP-Rab11 was seen (Fig.
6E). Furthermore, time-lapse imaging showed that many of the
structures double labeled with the two fluorophores displayed
the characteristic rapid, saltatory movement in which particles
sometimes reversed direction (see Movie S6 in the supplemen-
tal material).
We next tested whether the colocalization and cotrafficking
of NP, vRNA, and Rab11 in cells reflected an interaction that
could be detected biochemically. Cells were transfected with
GFP-Rab11 CA or, as negative controls, with GFP-Rab11 DN,
GFP-Rab8 CA, or GFP alone. GFP-Rab11 DN does not co-
localize with NP in infected cells, while Rab8 is not known to
play a role in the influenza virus life cycle (10). Following virus
superinfection, cell lysates were prepared and analyzed by
Western blotting for GFP and selected viral proteins before or
after fractionation over GFP-affinity beads. The P proteins,
NP, M1, M2, and various GFP polypeptides were detected as
expected in the cell lysates (Fig. 8A, lanes 1 to 5). GFP-
containing polypeptides also were retained as expected on the
anti-GFP beads (lanes 6 to 10). Only trace quantities of M1 or
M2 were detected in any of the bound fractions. However, NP
and the P proteins were readily detectable in the sample con-
taining GFP-Rab11 CA, while only background amounts were
seen in samples containing GFP-Rab11 DN or GFP-Rab8 CA
proteins (Fig. 8A, compare lane 7 to lanes 6, 9, and 10). The
quantification of the amounts of the viral proteins bound under
various conditions from replicate experiments showed that the
protein components of the viral RNP were consistently precip-
itated by GFP-Rab11 CA at around 10 times the level obtained
with GFP alone or with GFP Rab11 DN, Rab8 CA, or Rab4
CA (Fig. 8B), strongly suggesting that RNPs interact with the
GTP-bound form of Rab11. In confirmation of this, vRNA also
was directly detected in samples affinity purified with GFP-
Rab11 CA but not the other GFP polypeptides (Fig. 8C). To
determine which component of the influenza virus RNP inter-
acts with GTP-bound Rab11, we cotransfected the individual
RNP subunits with GFP-Rab11 CA or GFP and performed
GFP-affinity pulldowns. No detectable amounts of NP, PB1, or
PA were precipitated under these conditions despite their
presence in the starting cell lysates, whereas PB2 was specifi-
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cally bound by GFP-Rab11 CA but not by GFP alone (Fig.
8D). When replicate experiments were quantified, levels of
PB2 bound by GFP-Rab11 were around 6-fold higher than
those precipitated by GFP alone, while the amounts of PB1,
PA, and NP were similar for both ligands (Fig. 8E). These
data are consistent with the microscopy data showing the
colocalization of viral RNPs with WT or CA forms of Rab11
(Fig. 3, 5, and 6) but not the DN form (10) and support the
FIG. 6. Live-cell trafficking of GFP-NP and RFP-Rab11. 293T cells were transfected with plasmids to reconstitute viral RNPs containing segments 7 and
8 plus either GFP-NP (A to D) or GFP-NP and RFP-Rab11 (E) before imaging under time-lapse conditions (approximately every 4 s) at 24 h posttransfection.
(A and E) Single images at time zero are shown in the large panels with the tracks of selected particles indicated, while individual frames with single moving
particles highlighted with arrowheads are shown in the small panels. For example, track 1 shows saltatory class movement followed by Brownian-type movement,
and track 2 is classified as processive-type movement. Note that in panel E the apparent spatial separation of red and green images of fast-moving particles is
likely to be an artifact resulting from the time taken for the microscope to switch between channels. (B to D) Particle speeds were measured between consecutive
frames of time-lapse movies using ImageJ. Each data point represents one measurement between consecutive frames. (B and C) Values from untreated cells
were grouped according to whether the particles demonstrated nondirectional Brownian-type motion (random), steady processive motion, or saltatory/
bidirectional motion during the course of individual movies. A partial data set of saltatory movement, excluding a small number of very fast moving particles,
is plotted in panel B to avoid the visual compression of the lower-value data points, while the full data set is plotted separately in panel C. A total of 98 particles
from 16 cells from 10 independent transfections were analyzed. (D) Values from cells treated with the indicated drugs or left untreated (pooled data from panel
B) are plotted. A minimum of 54 particles from between 7 and 16 cells from two to three independent experiments were analyzed, focusing on the fastest moving
particles within the cells. Red bars indicate the means SEM. Asterisks indicate the outcome of statistical tests (nonparametric, two-tailed Mann-Whitney t test)
for differences between the treated and untreated samples. ***, P 	 0.001; **, P 	 0.01. Also see Movies S2 to 4 and 6 in the supplemental material.
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hypothesis that RNPs traffic via an Rab11-dependent path-
way potentially mediated by an interaction with the PB2
subunit of the polymerase.
We recently showed that the siRNA-mediated depletion of
Rab11 in 293T cells caused defects in influenza A virus bud-
ding without obvious alterations to NP localization (10). How-
ever, we did not examine vRNA localization directly, and 293T
cells have a small cytoplasmic volume, which may have masked
more subtle effects on NP trafficking. We therefore examined
the effect the loss of Rab11 had on vRNA distribution in A549
cells, which have a much larger cytoplasm/nuclear ratio. Cells
were depleted of Rab11a and Rab11b isoforms by siRNA
treatment as before (10); Western blot analysis of Rab11a and
selected viral proteins confirmed the effective knockdown of
Rab11 without major effect on viral gene expression (Fig. 9A).
When replicate experiments were quantified, an average de-
pletion of around 90% was obtained. We then examined the
effect this had on RNP localization across a time course of
virus infection. In cells treated with control siRNA oligonucle-
otides, vRNA and NP displayed time-dependent changes in
localization similar to those seen in other cell types: early
nuclear accumulation (with NP but not vRNA, tending to
concentrate toward the nuclear periphery), followed by in-
creasing cytoplasmic accumulation at later time points (Fig.
9B). The cytoplasmic phase of RNP localization included the
initial accumulation of vRNA at a perinuclear site (Fig. 9B, 7
h, arrowheads), which in some cells apparently was associated
with filamentous or tubular structures (Fig. 9B, 7 h, inset). At
later time points, the perinuclear vRNA staining was lost,
being replaced by many large (1-m) aggregates dispersed
throughout the cytoplasm, which mostly double stained for
both vRNA and NP (Fig. 9B, 10- and 16-h time points, and C).
In cells depleted of Rab11, vRNA still accumulated in the
nucleus at an early time point and was successfully exported to
the cytoplasm thereafter (Fig. 9D). However, the pattern of
RNP localization in the cytoplasm was considerably altered, as
the initial perinuclear accumulation and the subsequent large
cytoplasmic structures were absent, being replaced instead
with a much more dispersed, finer-grained pattern of staining
(Fig. 9C and D). Thus, the depletion of Rab11 leads to altered
vRNA trafficking in A549 cells.
Finally, we asked whether NP and Rab11 interacted in in-
fected A549 cells, since the majority of our previous data came
from 293T cells and overexpressed Rab11. Attempts to detect
an interaction between endogenous Rab11 and RNPs by pull-
down assay were unsuccessful (from A549 or 293T cells; data
not shown). We therefore turned to the Duolink PLA in situ
cell-based fluorescence proximity assay, in which closely ap-
posed (40 nm or less) primary antibodies are detected by the
amplification of intermolecular ligation events of oligonucleo-
tides covalently attached to secondary antibodies (54). When
cells were double stained by this procedure for NP and either
Rab11 or Rab4 (as a negative control), the numbers of de-
tected events were around 70-fold higher in infected cells than
in mock-infected cells for Rab11 but were only around 15-fold
higher for Rab4 (Fig. 9E). In cells first depleted of Rab11,
however, levels of signal from Rab11 and NP but not Rab4 and
NP were drastically reduced, indicating the specificity of the
reaction. Thus, while not proving a physical interaction, NP
and Rab11 normally are in close proximity during infection.
To provide information on where the NP-Rab11 interaction
occurred in A549 cells, we performed conventional indirect
immunofluorescence. In uninfected A549 cells, endogenous
Rab11 was difficult to detect by this method, producing faint
punctate staining throughout the cytoplasm as well as the more
distinct labeling of a perinuclear structure likely to be the RE
(Fig. 10). Unexpectedly, Rab11 staining was markedly more
intense in infected cells. At 7 h p.i., brighter punctate staining
throughout the cytoplasm was apparent, and in many cells,
there was prominent perinuclear staining with obvious colocal-
ization with NP (Fig. 10, arrows). Late in infection, large cy-
toplasmic aggregates of Rab11 appeared that again colocalized
strongly with NP (Fig. 10, 16 h p.i.). The virus-induced increase
in the intensity of Rab11 staining did not result from increased
amounts of the protein, as judged by Western blot analysis
(Fig. 9A), but it was not artifactual cross-reactivity with an-
other antigen, since infected cells depleted of Rab11 by siRNA
treatment displayed very low levels of staining (Fig. 10). One
possibility is that the more concentrated protein facilitates
detection, although an infection-dependent unmasking of the
FIG. 7. FRAP analysis of the perinuclear compartment. RNPs
were reconstituted in 293T cells as described in the legend to Fig. 5,
and perinuclear areas of fluorescence were subjected to FRAP analy-
sis. (A) Representative images from one cell (colored according to
fluorescence intensity in arbitrary units) are shown. The scale bar is 5
m, and the red square denotes the bleach area. (B) The mean SEM
(n  24) recovery curve is plotted. (C) The fraction of initial fluores-
cence recovered at 85 s after the bleaching of individual cells is plotted.
Horizontal lines indicate the means  SEM. Also see Movie S5 in the
supplemental material.
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Rab11 C-terminal sequence recognized by the antibody also is
possible. The depletion of Rab11 did, however, again lead to
the altered cytoplasmic distribution of NP as previously ob-
served for vRNA (Fig. 9D and 10). Overall, therefore, RNPs
colocalized with Rab11 in A549 cells, and the loss of Rab11
altered their pattern of cytoplasmic localization. This supports
the hypothesis that the cytoplasmic trafficking of the influenza
virus genome involves Rab11.
DISCUSSION
Our aim was to better define the trafficking mechanism(s)
responsible for the transport of the influenza A virus genome
from the nuclear to plasma membranes. Using a combination
of static and live-cell imaging techniques, we provide evidence
for two distinct patterns of vRNA localization in the cytoplasm
(perinuclear and dispersed cytoplasmic granules), as well as
evidence that RNPs traffic in part using the microtubule-based
vesicular transport system, and that the adaptor linking viral
and cellular components for this process is Rab11. We inter-
pret our data as supporting a two-step model for the cytoplas-
mic trafficking of the viral genome, in which after leaving the
nucleus, RNPs first accumulate at the pericentriolar recycling
endosomal compartment through an interaction with Rab11
and then piggyback onto the microtubule network via vesicles
destined for the cell periphery (Fig. 11).
The perinuclear accumulation of NP and vRNA has been
noted before (10, 28, 34). Here, we extend this observation by
showing that it is a time-dependent phenomenon occurring
midway through infection, that it can be seen in living cells, and
that it occurs with several strains of virus in different cell types,
making it likely that it reflects an important feature of the viral
life cycle. We also identify the location as the pericentriolar
recycling endosomal compartment. We base this on the failure
of vRNA to meaningfully colocalize with other cellular vesic-
ular markers found in this region of the cell, including cis and
FIG. 8. Biochemical association of RNPs and Rab11. (A to C) 293T cells were transfected with plasmids expressing GFP alone or the indicated
GFP-Rab proteins (11C, Rab11 CA; 11D, Rab11 DN; 8C, Rab8 CA) and infected (or mock infected) 48 h later with PR8 virus. (A) Cell lysates
prepared at 6 h p.i. were analyzed by Western blotting for the indicated polypeptides after GFP-Trap affinity selection into supernatant and bound
fractions. Sample loading is such that the supernatants are equivalent to 1/10 the bound fractions. (B) Bound protein was quantified from replicate
experiments and is plotted as the mean  SEM fold increase relative to levels for the GFP control. (C) RNA was analyzed by primer extension
for segment 7 vRNA and 5S rRNA before (total) or after GFP-TRAP selection. (D and E) 293T cells were transfected with the indicated plasmids
and analyzed by GFP-TRAP affinity selection followed by Western blotting as for panels A and B.
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trans compartments of the Golgi network, as well as markers
for early endosomes or aggresomes (data not shown). Evi-
dence in favor of this is that vRNA and Rab11a overlap was
significant, while GFP-NP-tagged RNPs also colocalized near
the MTOC with transferrin (data not shown). Both Rab11a
and transferrin serve as markers for the pericentriolar RE
compartment (20, 43, 56). The apparently tubular localization
pattern seen for vRNA in a subset of A549 cells also is con-
sistent with localization at the RE (25). However, we disagree
with previous conclusions that perinuclear RNPs colocalized
with markers for the TGN (28, 34).
We propose that vRNAs accumulate at the pericentriolar
RE first before moving to the periphery of the cell. This aspect
of the model is based on the observations that vRNA localiza-
tion here is seen soon after the onset of genome replication
and export and that it tends to fade later in infection, suggest-
ing a dynamic rather than static association. Further support-
ing this, the observation of GFP-tagged NP particle movement
in living cells was consistent with the movement of RNPs both
into and out of the perinuclear body during relatively short
time scales. It also is supported by the persistence of vRNA
staining in the perinuclear region after vesicular transport in
infected cells was blocked by treatment with monensin. The
model also is consistent with the known directionality of Rab11
in directing vesicular trafficking from the RE to the plasma
membrane (43, 56, 59).
We hypothesize that an interaction between PB2 and
Rab11 recruits the viral genome to the pericentriolar RE
FIG. 9. Effect of siRNA depletion of Rab11 on RNP localization. A549 cells were transfected or mock transfected (
) with siRNAs against
Rab11a and Rab11b (Rab11) or with a nontargeting control (NT) and infected or mock infected 3 days later with PR8 virus as indicated. (A) At
16 h p.i., cell lysates were analyzed by Western blotting for the indicated proteins. (B to D) A549 cells were treated with nontargeting (NT) or
(D) with siRNAs against Rab11a and Rab11b, infected 3 days later with PR8 virus, fixed at the indicated times p.i., and stained for segment 4 vRNA
and NP. Merged-image panels also show 4,6-diamidino-2-phenylindole (DAPI) staining for nuclei. All images were collected at equal microscope
settings, but the 4-h panels are shown at increased brightness. Scale bars, 5 m. (C) The percentage (means  SE) of cells showing an obvious
perinuclear accumulation of vRNA was scored at various times p.i. (E) Cells were fixed and analyzed for NP proximity to the indicated Rab
proteins by a Duolink PLA fluorescence proximity assay. The number of fluorescent spots per nuclei (360 cells) of single optical sections were
counted and are presented as the mean  SEM (n  2 to 3 independent experiments) increase above levels for similarly stained mock-infected
cells.
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based on the finding that all components of an RNP can be
specifically coprecipitated by the GTP-bound form of Rab11
from infected cells but only PB2 as an individual protein,
and that in the absence of normal levels of Rab11 RNPs do
not concentrate at the perinuclear site. Also, their cytoplas-
mic localization in general is altered. The simplest hypoth-
esis is a direct protein-protein interaction between PB2 and
Rab11, but at present we cannot rule out bridging interac-
tions with other cellular proteins, such as a Rab11-family
interacting protein.
In a refinement of a recent proposal that RNP trafficking
involves the vesicular transport system (28), we also postulate
that RNP transport to the cell periphery is at least partly based
on an attachment to Rab11-positive vesicles that move via
microtubules, which is consistent with the known transport of
such cellular cargo (3, 7, 13). In evidence of microtubule-based
movement of RNPs, the speeds and saltatory character exhib-
ited by many GFP-NP particles in time-lapse movies of living
cells are diagnostic as well as consistent with the values mea-
sured for the movement of intracellular enveloped vaccinia
virus on microtubules (44, 57). We also point to the disruption
of normal vRNA localization seen after treatment with specific
inhibitors of the microtubule network. Similar perturbations of
cytoplasmic NP localization after treatment with inhibitors of
microtubule function have been reported previously (34). The
apparent misdirection of vRNA to the lateral membranes of
MDCK cells after nocodazole treatment also is consistent with
a study that found a loss of polarity in virus budding under
similar circumstances (45). It is worth noting that nocodazole
treatment has been shown previously to disperse Rab11-posi-
tive vesicles, resulting in an accumulation at the lateral mem-
branes (3, 13). Evidence for RNP trafficking piggybacking on
vesicles is less direct, as at present we cannot formally exclude
a mechanism in which RNPs are targeted to microtubules
without an intervening lipid structure. However, we think this
hypothesis is reasonable given the extensive colocalization be-
tween NP, vRNA, and both WT and CA forms of Rab11 and
the fact that the GTP-bound form of Rab11 would be expected
to be membrane bound. It also is consistent with the observa-
FIG. 10. Colocalization of Rab11 and NP in A549 cells. Cells were
infected or mock infected with PR8 virus, fixed at 16 h p.i., and stained
for NP and Rab11. Scale bar, 10 m.
FIG. 11. Cartoon model for influenza virus RNP trafficking. RNPs are replicated within the nucleus and exported via cellular Crm1 and viral
NEP and M1 proteins. They initially concentrate at the pericentriolar recycling endosome (RE) adjacent to the microtubule organizing center
(MTOC) through interactions with Rab11. Subsequently, they traffic along the microtubule network toward the cell periphery and plasma
membrane (PM) on Rab11-positive cargo vesicles.
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tion that monensin treatment throughout infection inhibits
vRNA movement away from the RE.
We would not argue that all RNP transport occurs via the
model just described. While we measured saltatory movement
consistent with microtubule-based trafficking for some RNP
particles, others exhibited diffusional-type movement, similarly
to that previously observed for microinjected RNPs (6). Other
GFP-NP particles exhibited short-range processive movement
with an average speed of around 0.2 m/s, which is consistent
with actin-based motility (44). These observations, together with
the relatively minor effects of microtubule-disrupting drugs on
virus replication and the diffuse localization of vRNA in
Rab11-depleted cells, make it plausible that redundant mech-
anisms apply in transporting vRNPs to the plasma membrane.
We hypothesize that microtubules are required for the efficient
long-range delivery of RNPs, while other modes of transport
(i.e., diffusion or along microfilaments) also operate, poten-
tially over shorter ranges and/or in different areas of the cell. A
degree of functional redundancy may explain the relatively
minor effects cytoskeletal poisons have on the overall titer of
virus replication in cell culture.
Our model for vRNA trafficking may have parallels with
certain other viruses. Notably, the capsid assembly of certain
retroviruses has been proposed to take place at the pericentri-
olar RE (1), and this region of the cell also may be used as a
way point by several large DNA viruses (60). Most notably,
however, our findings are strikingly similar to those recently
reported for the nonsegmented negative-sense Sendai virus, in
which the colocalization of viral RNPs and Rab11a as well as
the microtubule-based movement of the RNPs was shown (14).
Previous work in our laboratory (10) showed that Rab11 was
required for virus budding. However, the question of whether
Rab11 was directly involved in mediating membrane scission
or indirectly linked (by transporting a viral or cellular factor
essential for pinching off) was not resolved in our earlier work.
We did not observe a notable NP-trafficking defect in Rab11-
depleted 293T cells (10), in contrast to the greatly altered
distribution of NP and vRNA seen in depleted A549 cells here.
A549 cells, as human lung cells with considerable cytoplasmic
volumes, represent a more authentic model to study viral traf-
ficking. The discrepancies seen in some circumstances between
the indirect immunofluorescent staining of NP and FISH stain-
ing of vRNA (e.g., Fig. 1B, 4-h time points, and Fig. 9, 4- and
16-h time points) also raise the possibility of separate pools of
free NP in the cytoplasm and nucleus. Nevertheless, the role of
Rab11 in influenza RNP trafficking presented here is consis-
tent with the theory that Rab11 is indirectly involved in viral
budding. One possibility is that Rab11 also is required for the
efficient delivery of M2 to the apical plasma membrane (48).
However, the possibility that the trafficking of the viral genome
is specifically required to allow efficient virus assembly and/or
budding is an attractive hypothesis and is one that represents
an area of future research.
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